| Name | benzyl N-(2-hydroxyethyl)-N-methylcarbamate |
|---|---|
| Synonyms |
Cbamic acid, N-(2-hydroxyethyl)-N-methyl-, phenylmethyl ester
N-Cbz-2-(methylamino)ethanol Benzyl N-(2-hydroxyethyl)-N-methyl-cbamate Cbamic acid, (2-hydroxyethyl)methyl-, phenylmethyl ester benzyl (2-hydroxyethyl)(methyl)cbamate N-benzyloxycarbonyl-2-methylamino-ethanol N-benzyloxycarbonyl-N-methyl-2-aminoethanol N-CBZ-N-METHYL-2-AMINOETHANOL 2-[Cbz-(methyl)amino]ethanol (2-Hydroxy-ethyl)-Methyl-cbaMic acid benzyl ester |
| Molecular Formula | C11H15NO3 |
|---|---|
| Molecular Weight | 209.24200 |
| Exact Mass | 209.10500 |
| PSA | 49.77000 |
| LogP | 1.24730 |
|
~97%
67580-96-5 |
| Literature: THERAVANCE, INC. Patent: WO2004/89892 A2, 2004 ; Location in patent: Page 90 ; WO 2004/089892 A2 |
|
~%
67580-96-5 |
| Literature: Bristol-Myers Squibb Company Patent: US6506738 B1, 2003 ; |
| Precursor 3 | |
|---|---|
| DownStream 1 | |